25 results
8-K
EX-4.1
NBSE
NeuBase Therapeutics Inc
18 Oct 23
Entry into a Material Definitive Agreement
8:00am
8-K
EX-4.1
NBSE
NeuBase Therapeutics Inc
30 Jun 23
NeuBase Announces $5 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules
4:21pm
8-K
EX-4.3
NBSE
NeuBase Therapeutics Inc
30 Jun 23
NeuBase Announces $5 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules
4:21pm
8-K
EX-4.5
NBSE
NeuBase Therapeutics Inc
30 Jun 23
NeuBase Announces $5 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules
4:21pm
8-K
EX-4.4
NBSE
NeuBase Therapeutics Inc
30 Jun 23
NeuBase Announces $5 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules
4:21pm
8-K
EX-4.2
8m08o2r0y99
30 Jun 23
NeuBase Announces $5 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules
4:21pm
S-8
EX-4.6
gjxiuwm9w9pq
16 Aug 19
Registration of securities for employees
5:02pm
S-8
EX-4.8
6zif2hfe 6lu
16 Aug 19
Registration of securities for employees
5:02pm
S-8
EX-4.17
u87y zjdshuod13n
16 Aug 19
Registration of securities for employees
5:02pm
8-K
EX-4.1
162h8
6 Apr 17
OHR PHARMACEUTICAL Announces Pricing of $14.175 Million Public Offering of Common Stock and Warrants
12:00am
8-K
EX-4.1
enkry5onxw0r
4 Apr 17
Ohr Pharmaceutical Announces Proposed Public Offering of Common Stock and Warrants
12:00am
8-K
EX-4.1
u9a1msbky
8 Dec 16
Ohr Pharmaceutical Announces Proposed Public Offering of Common Stock and Warrants
12:00am
8-K
EX-4.2
n540pg27
8 Dec 16
Ohr Pharmaceutical Announces Proposed Public Offering of Common Stock and Warrants
12:00am